Brief: Hcw Biologics Reports Fourth Quarter And Full Year 2022 Financial Results And Recent Business Highlights
28/03/2023 23:33
March 28 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
* HCW BIOLOGICS INC - BELIEVES ITS CASH AND CASH EQUIVALENTS
AND
INVESTMENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS THROUGH AT
LEAST NEXT 12 MONTHS
* HCW BIOLOGICS INC - QTRLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nGNXc0sJr9
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM